Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety

Hypochondriasis Clinical Trial

Official title:

Internet-delivered Acceptance and Commitment Therapy for Patients With Health Anxiety: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02735434
• Other study ID #: 09032016
• Status: Completed
• Phase: N/A
• Start date: April 2016
• Est. completion date: March 2018

Study information

• Verified date: March 2017
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Health anxiety is a prevalent, disabling disorder associated with extensive health care expenditures. The lack of easily accessible, evidence-based psychological treatment combined with delayed diagnostic recognition constitute barriers to receiving treatment. Aim 1. To develop an internet-delivered treatment program, based on 'Acceptance and Commitment Therapy' (ACT), for patients with health anxiety. 2. To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing the treatment with an active control condition. Methods 150 patients aged 18 years and older can self-refer through a web-page to apply for participation. Before inclusion patients will undergo a video-diagnostic interview. Patients are randomly assigned to 12 weeks of either, 1) active treatment: consisting of internet-based ACT (iACT) with 7 therapist-guided modules of self-help text, exercises, patient videos and audio-files, or 2) active control condition: consisting of an internet-based discussion forum (iFORUM) with 7 topics of discussion. All patients will complete self-report questionnaires at baseline, before randomization, at 4 and 8 weeks into treatment, after end of treatment, and at 6-month follow-up.

Description:

Severe health anxiety (illness anxiety disorder) or hypochondriasis, according to the psychiatric classification system ICD-10, is characterized by preoccupation with fear of having a serious illness, which interferes with daily functions and persists despite medical reassurance. Clinical significant health anxiety is prevalent in primary care with 0.8-9.5%, and has a lifetime prevalence of 5.7% in the general population. It is a disabling disorder, associated with extensive use of health care services and occupational disability. Earlier, health anxiety has been considered a chronic disease with poor treatment outcomes. A recent review found effect of both medicine and psychotherapy, but patients may prefer psychotherapeutic treatments. Despite the high prevalence, health anxiety is rarely diagnosed within primary care, and there is limited access to evidence-based treatment for health anxiety. An easily accessible, evidence-based treatment is needed for this debilitating condition. Internet-based treatment is a new approach where patients receive access to a guided self-help program. A meta-analysis has shown equal treatment effects of internet-based treatment compared to "face-to-face" treatment for depressive- and anxiety disorders. Internet-based cognitive behavioral therapy for health anxiety has shown to be cost-effective. ACT is a new effective generation of cognitive-behavioral therapy, with an emphasis on acceptance and value-based exposure that has shown good results for treating health anxiety in a group setting. Internet-based Cognitive behavioral therapy (CBT) for health anxiety has shown promising results but low treatment completion. This may be due to the comprehensive treatment modules and the text-based format. ACT is an experiential behavioral therapy, and aims to activate patients with exercises, videos, audio-files and less text material. Most persons with health anxiety have high health care expenditure. However, some patients with health anxiety avoid contact to the health care system, and may not receive proper treatment. Patient self-referral is a new approach that may facilitate access to treatment. Aim 1. To develop an internet-delivered treatment program for patients suffering from health anxiety based on ACT. 2. To test the feasibility and effectiveness of the treatment programme in a randomized, controlled trial, comparing treatment with an active control condition. Hypothesis Primary hypothesis Patients with health anxiety treated with iACT will at 6-month follow-up report a significant reduction in illness worry compared to the action control condition iFORUM. Secondary hypotheses Patients with health anxiety treated with iACT compared to the active control condition iFORUM will at 6-month follow-up report: 1. a reduction in physical symptoms and symptoms of anxiety and depression 2. increased health-related quality of life 3. more expedient illness perceptions and increased acceptance of symptoms Mediation analyses 4. changes in illness perception and acceptance mediate the effect of iACT

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: March 2018
• Est. primary completion date: April 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Severe health anxiety > 6 months

2. Whiteley-7 score (scale 0-100 score points) corresponding to 21,4 or more.

3. Age above 18 years old

4. In case of a comorbid functional or other psychiatric disorder health anxiety must be the dominant problem

5. Patients who speak, read and write Danish

6. Access to a computer and internet access

7. Residence in Denmark

Exclusion criteria:

1. Acute suicidal risk

2. Abuse of narcotics or alcohol and (non-prescribed) medicine

3. Lifetime-diagnosis of psychoses, bipolar affective disorder or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)

4. Pregnancy

5. Unstable psychopharmacological treatment within last 2 months

6. Former treatment at the Research Clinic for Functional Disorders and Psychosomatics

7. Not providing informed consent

Related Conditions & MeSH terms

• Hypochondriasis

Intervention

Behavioral:
• Internet-based ACT
The guided internet program consists of 7 modules activated consecutively over a period of 12 weeks. The content is written psycho education, patient videos, audio-exercises and behavioural exposure exercises. The program is therapist-guided; hence all patients will receive support from primarily the same therapist during the 12 weeks.

Other:
• Internet-based discussion forum
The online discussion forum consists of 7 themes touching upon the impact of health anxiety and the patients own coping strategies. The themes are activated consecutively over a period of 12 weeks. The discussion forum is text-based, and only patients will participate in the discussion. The written discussions will be reviewed by a professional for ethical reasons. The discussion forum aims to control for the effect of attention and contacts to the health care system. After 9 months patients in the discussion forum are offered active treatment, but not as part of the research project.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
University of Aarhus	Aarhus University Hospital, Karolinska Institutet

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Psychological flexibility measured with the Acceptance and Action Questionnaire-II (AAQ-II)		At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation
Other	Non-reactivity measured with a subscale of the Five Facet Mindfulness Questionnaire (FFMQ)		At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation
Other	Illness perception measured with the Brief Illness Perception Questionnaire (B-IPQ)		At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation
Other	Personality traits measured with the short version of the Big Five Inventory (BFI-10)		Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)
Other	Working alliance measured with the Working Alliance Inventory, Patient version (WAI-pt)		2 weeks into treatment, and 3 months after randomisation
Other	Treatment credibility and expectancy measured with the credibility/ expectancy questionnaire		Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)
Other	Childhood history questionnaire		Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)
Other	Traumatic events in childhood measured with the Childhood traumatic event scale		Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)
Other	Attachment style measured with the questionnaire: Experiences in close relationships - relationship structures (ECR-RS)		Before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline)
Other	Treatment evaluation of negative effects measured with the Inventory for the assessment of negative effects of psychotherapy (INEP)		9 months after randomisation
Other	Attitudes toward seeking professional help		At baseline (i.e. at self-referral) and at 3 months after randomisation
Other	Self-reported health care use, work performance and work absence measured with Trimbos/ institute of Health Policy and Management (iMTA) questionnaire for Costs associated with Psychiatric Illness (TiC-P)		At baseline (i.e. at self-referral) and at 9 months after randomisation
Other	Health care expenditures extracted from Danish national registers, and degree of illness related absence from work extracted from the Danish Register of Sickness absence compensation benefits and Social transfer payments database (DREAM).		At baseline (i.e. at self-referral) and at 9 months after randomisation
Other	Health literacy measured with the Health Literacy Questionnaire (HLQ)		At baseline (i.e. at self-referral)
Other	Values measured with the Sources of Meaning and Meaning in life questionnaire (SoMe-26)		At baseline (i.e. at self-referral), and 1, 2, 3 and 9 months after randomisation
Other	Negative events and effects of psychological treatment		At 3 months after randomisation
Primary	Whiteley-7 index	Health anxiety symptoms	At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation
Secondary	Demographic questions measured with questions from the Danish study for Functional Disorders (DanFund)		At baseline (i.e. at self-referral)
Secondary	Diagnosed somatic illnesses measured with questions from the Danish study for Functional Disorders (DanFund)		At baseline (i.e. at self-referral)
Secondary	Quality of life measured with the World Health Organisation Well-being Index-Five (WHO-5)		At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation
Secondary	Quality of life measured with the visual analogue scale (VAS question) from Youth profile, National Institute of Public Health		At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation
Secondary	Stress measured with questions from the survey Youth stress, Danish Health Authority		At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline) and 1, 2, 3 and 9 months after randomisation
Secondary	Health anxiety symptoms measured with the Short Health Anxiety Inventory (SHAI)		At baseline (i.e. at self-referral), and 3 and 9 months after randomisation
Secondary	Anxiety, depression, obsessive-compulsive and physical symptoms measured with subscales from the Symptom Checklist (SCL-92)		At baseline (i.e. at self-referral), and 3 and 9 months after randomisation
Secondary	Somatisation measured with the Bodily Distress Syndrome Checklist (BDS Checklist)		At baseline (i.e. at self-referral)
Secondary	General health status and functioning measured with the Short Form 12 Health Survey (SF-12)		At baseline (i.e. at self-referral), before randomisation (i.e. after clinical assessment and up to 6 weeks after baseline), 3 and 9 months after randomisation

External Links

•   Homepage for the Research Clinic for Functional Disorders, Aarhus University Hospital